Hans-Georg Hacker
Overview
Explore the profile of Hans-Georg Hacker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
29
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Vicente Martin C, Stocker S, Bautista M, Rogue V, Steib-Lauer C, Hacker H, et al.
Drug Dev Ind Pharm
. 2022 Jul;
48(5):211-225.
PMID: 35861393
Objective: This work summarizes select methodology of twin-screw melt granulation (TSMG) and process analytical technology that were used in the successful scaling-up and commercial transfer of high drug load (80.5%...
2.
Hacker H, Tekeste Sisay M, Gutschow M
Pharmacol Ther
. 2011 Aug;
132(2):180-95.
PMID: 21807025
Caspases are proteolytic enzymes mainly involved in the induction and execution phases of apoptosis. This type of programmed cell death is an essential regulatory process required to maintain the integrity...
3.
Hacker H, Meusel M, Aschfalk M, Gutschow M
ACS Comb Sci
. 2011 Jan;
13(1):59-64.
PMID: 21247126
Acylureas (ureides) are valued for their important biological activities. Whereas cyclic acylureas have frequently been the object of solid-phase chemistry, only few reports have focused on the solid-supported preparation of...
4.
Ottersbach P, Elsinghorst P, Hacker H, Gutschow M
Org Lett
. 2010 Jul;
12(16):3662-5.
PMID: 20666472
A facile synthesis of 2H-3,1-benzothiazine-2,4(1H)-dithiones (trithioisatoic anhydrides) or 2H-naphtho[2,3-d][1,3]thiazine-2,4(1H)-dithione solely from anthranilic acids or 3-amino-2-naphthoic acid and carbon disulfide, performed at room temperature in 1,4-dioxane in the presence of Et(3)N,...
5.
Hacker H, de la Haye A, Sterz K, Schnakenburg G, Wiese M, Gutschow M
Bioorg Med Chem Lett
. 2009 Sep;
19(21):6102-5.
PMID: 19783433
P-glycoprotein (P-gp) is an important factor in the development of multidrug resistance (MDR) in cancer cells. In literature reports, a thieno[2,3-d]pyrimidine (QB13) was described as P-gp modulator and opposed effects...
6.
Hacker H, Leyers S, Wiendlocha J, Gutschow M, Wiese M
J Med Chem
. 2009 Jul;
52(15):4586-95.
PMID: 19580319
Four series of aromatic carboxylic acids were prepared with a urea or thiourea moiety at the neighboring position to the carboxyl group and benzene or thiophene as aromatic scaffold. Using...
7.
Hacker H, Grundmann F, Lohr F, Ottersbach P, Zhou J, Schnakenburg G, et al.
Molecules
. 2009 Jan;
14(1):378-402.
PMID: 19145216
The synthetic access to 2-sec-amino-4H-3,1-benzothiazin-4-ones 2 was explored. Compounds 2 were available from methyl 2-thioureidobenzoates 1, 2-thioureidobenzoic acids 3, and novel 2-thioureidobenzamides 6, respectively, under different conditions. 2-Alkylthio-4H-3,1-benzothiazin-4-ones 5 have...
8.
Leyers S, Hacker H, Wiendlocha J, Gutschow M, Wiese M
Bioorg Med Chem Lett
. 2008 Aug;
18(17):4761-3.
PMID: 18707884
We present a novel lead for inhibitors of multidrug resistance-associated proteins (MRPs). Compound 1 (4-[(5,6,7,8-tetrahydro-4-oxo-4H-[1]benzothieno[2,3-d][1,3]thiazin-2-yl)amino]benzoic acid) was about six times more potent than the known inhibitor MK571 at MRP1, while...